title: CD56(bright) natural killer cells expand and contract irrespective of CD25 antibody treatment in kidney allograft recipients.
authors.forename: G
authors.initials: G
authors.lastname: Zenhaeusern
authors.forename: G
authors.initials: G
authors.lastname: Hönger
authors.forename: O
authors.initials: O
authors.lastname: Gasser
authors.forename: J
authors.initials: J
authors.lastname: Steiger
authors.forename: S
authors.initials: S
authors.lastname: Schaub
authors.forename: C
authors.initials: C
authors.lastname: Hess
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D019002:CD56 Antigen / Q000276:immunology*; D005260:Female; D006801:Humans; D053645:Interleukin-2 Receptor alpha Subunit / Q000276:immunology*; D016030:Kidney Transplantation / Q000276:immunology* / Q000379:methods; D007694:Killer Cells, Natural / Q000166:cytology / Q000187:drug effects / Q000276:immunology*; D018655:Lymphocyte Count; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014184:Transplantation, Homologous
chemical_list: D000911:Antibodies, Monoclonal; D019002:CD56 Antigen; D053645:Interleukin-2 Receptor alpha Subunit